KDM4A Silencing Reverses Cisplatin Resistance in Ovarian Cancer Cells by Reducing Mitophagy <i>via</i> SNCA Transcriptional Inactivation
Silencing of KDM4A-mediated transcription inactivation of SNCA reduces mitophagy, thus inhibiting the resistance of ovarian cancer cells to cisplatin. KDM4A may be a promising drug target for DDP-resistant ovarian cancer cells.
Authors
- Huiqing Ding (ORCID: https://orcid.org/0000-0001-5175-3617)
- Meiya Mao
- Hongyan Shi (ORCID: https://orcid.org/0009-0002-4192-793X)
- Yan Xing (ORCID: https://orcid.org/0000-0002-2744-5283)
- Tianhong Zhu
Institutions
- Ningbo University (CN)
- Ningbo First Hospital (CN)
Publication Details
- Journal
- Current Molecular Medicine
- Published
- 2025-01-10
- DOI
- https://doi.org/10.2174/0115665240281083241112053145
- Citations
- 1
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.81